{
  "type": "hyp",
  "text": "Results indicated that (i) constitutive c-fos transcript levels are significantly higher in patients subsequently responding to IFN-alpha therapy (p  \u2047  0.01) and positively correlated with the proportion of lymphocytes (r = 0.6895 p  \u2047  0.01) and negatively with the proportion of immature cells (r = -0.568 p  \u2047  0.01) contained in the pbmc preparations tested (ii) constitutive mRNA levels of the hybrid bcr/abl c-myc and p53 are positively correlated with each other but failed to relate to disease parameters and (iii) acute and chronic in vivo exposure to IFN-alpha is accompanied by upregulation of c-fos and downregulation of c\n",
  "self": {
    "NER": {
      "answers": [
        "0.01",
        "0.6895",
        "0.01",
        "0.01",
        "bcr/abl c-myc",
        "vivo"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was the r value of the c-fos transcript?",
          "What was the r value of the proportion of lymphocytes in patients responding to IFN",
          "What was the r value of the c-fos transcript?",
          "What was the r value of the c-fos transcript?",
          "What is the mRNA level of p53?",
          "In what way are c-fos levels higher in patients responding to IFN-"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "Results",
        "i) constitutive c-fos transcript levels",
        "patients",
        "IFN-alpha therapy",
        "p",
        "the proportion",
        "lymphocytes",
        "the proportion",
        "immature cells",
        "r",
        "= -0.568 p",
        "the pbmc preparations",
        "ii",
        "the hybrid bcr/abl c-myc",
        "p53",
        "parameters",
        "vivo exposure",
        "IFN-alpha",
        "upregulation",
        "c-fos",
        "downregulation",
        "c"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What indicated that constitutive c-fos transcript levels are significantly higher in patients responding",
          "What is significantly higher in patients responding to IFN-alpha therapy?",
          "What is the constitutive c-fos transcript higher in?",
          "What is the main cause of the higher levels of constitutive c-fos in",
          "What is the sensitivity of the c-fos transcript?",
          "What is the correlated effect of IFN-alpha on the number of lymphocytes",
          "What is the proportion of immature cells in patients treated with IFN-alpha?",
          "What is the correlated effect of IFN-alpha on the number of lymphocytes",
          "What is negatively correlated with the proportion of lymphocytes?",
          "What is the correlation between the proportion of immature cells and constitutive c-f",
          "What was the r value of the proportion of immature cells in pbm",
          "What is positively correlated with the proportion of immature cells?",
          "What is the effect of IFN-alpha on the c-fos transcript",
          "What is positively correlated with the proportion of immature cells?",
          "What is the other gene that is negatively correlated with the proportion of immature cells?",
          "What do the results show about the disease?",
          "What is accompanied by upregulation of c-fos?",
          "What therapy is associated with higher constitutive c-fos levels?",
          "What is the effect of acute and chronic exposure to IFN-alpha?",
          "What is significantly higher in patients responding to IFN-alpha therapy?",
          "What is the effect of IFN-alpha on c-fos?",
          "What is the most important transcript of a human immune system?"
        ]
      }
    }
  },
  "asked": {
    "What was the r value of the c-fos transcript in patients responding to": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "p?? 0.01",
        "answerability": 0.6868423819541931,
        "ground_truth": {
          "0.01": {
            "bertscore": 0.8407133221626282,
            "f1": 0.6666666666666666
          }
        }
      }
    },
    "What was the r value of the proportion of lymphocytes in patients responding to IFN": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "p?? 0.01)",
        "answerability": 0.7125060558319092,
        "ground_truth": {
          "0.6895": {
            "bertscore": 0.7021759748458862,
            "f1": 0
          }
        }
      }
    },
    "What is positively correlated with the proportion of immature cells?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.08481967449188232,
        "ground_truth": {
          "bcr/abl c-myc": {
            "bertscore": 0.632674515247345,
            "f1": 0
          },
          "the hybrid bcr/abl c-myc": {
            "bertscore": 0.6224686503410339,
            "f1": 0
          },
          "c-myc mRNA levels": {
            "bertscore": 0.6204740405082703,
            "f1": 0
          }
        }
      }
    },
    "In what way are c-fos levels higher in responders to IFN-": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "positively correlated with the proportion of lymphocytes",
        "answerability": 0.9804254770278931,
        "ground_truth": {
          "vivo": {
            "bertscore": 0.6313573122024536,
            "f1": 0
          }
        }
      }
    },
    "What indicated that constitutive c-fos transcript levels are significantly higher in patients responding": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "Results",
        "answerability": 0.8442872166633606,
        "ground_truth": {
          "Results": {
            "bertscore": 0.9999999403953552,
            "f1": 1.0
          }
        }
      }
    },
    "What is significantly higher in patients responding to IFN-alpha therapy?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "constitutive c-fos transcript levels",
        "answerability": 0.9391188621520996,
        "ground_truth": {
          "i) constitutive c-fos transcript levels": {
            "bertscore": 0.9421008825302124,
            "f1": 0.888888888888889
          },
          "c-fos": {
            "bertscore": 0.7536272406578064,
            "f1": 0.4
          }
        }
      }
    },
    "What is the effect of IFN-alpha on the c-fos transcript": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "upregulation of c-fos and downregulation of c-fos",
        "answerability": 0.8531643748283386,
        "ground_truth": {
          "patients": {
            "bertscore": 0.6512556076049805,
            "f1": 0
          }
        }
      }
    },
    "What is the most effective treatment for a swine flu?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.21190094947814941,
        "ground_truth": {
          "IFN-alpha therapy": {
            "bertscore": 0.63325434923172,
            "f1": 0
          }
        }
      }
    },
    "What is the correlated effect of IFN-alpha on the number of lymphocytes": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "positive correlated with the proportion of lymphocytes",
        "answerability": 0.9636244773864746,
        "ground_truth": {
          "the proportion": {
            "bertscore": 0.6733599901199341,
            "f1": 0.2857142857142857
          }
        }
      }
    },
    "What is the proportion of immature cells in a patient who responds to IFN": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.39392614364624023,
        "ground_truth": {
          "lymphocytes": {
            "bertscore": 0.6273000836372375,
            "f1": 0
          }
        }
      }
    },
    "What is negatively correlated with the proportion of lymphocytes in a patient responding to I": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.27075523138046265,
        "ground_truth": {
          "immature cells": {
            "bertscore": 0.6963641047477722,
            "f1": 0
          }
        }
      }
    },
    "What is positively correlated with the proportion of immature cells in patients treated with IFN": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.42866945266723633,
        "ground_truth": {
          "the pbmc preparations": {
            "bertscore": 0.6310931444168091,
            "f1": 0
          }
        }
      }
    },
    "What is the relationship between c-fos and immature cells?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "negatively",
        "answerability": 0.9892706274986267,
        "ground_truth": {
          "ii": {
            "bertscore": 0.7352539300918579,
            "f1": 0
          }
        }
      }
    },
    "What is the other gene that is positively correlated with the proportion of immature cells?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.509604275226593,
        "ground_truth": {
          "p53": {
            "bertscore": 0.6259341239929199,
            "f1": 0
          }
        }
      }
    },
    "What do the results show about the disease?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.1425219178199768,
        "ground_truth": {
          "parameters": {
            "bertscore": 0.7021068334579468,
            "f1": 0
          }
        }
      }
    },
    "What is accompanied by upregulation of c-fos and downregulation of": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "acute and chronic in vivo exposure to IFN-alpha",
        "answerability": 0.9519569277763367,
        "ground_truth": {
          "vivo exposure": {
            "bertscore": 0.7089488506317139,
            "f1": 0.4
          }
        }
      }
    },
    "What therapy is associated with higher constitutive c-fos levels?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "IFN-alpha therapy",
        "answerability": 0.9673435688018799,
        "ground_truth": {
          "IFN-alpha": {
            "bertscore": 0.9193717241287231,
            "f1": 0.6666666666666666
          }
        }
      }
    },
    "What is the effect of IFN-alpha on c-fos transcript levels": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "significantly higher",
        "answerability": 0.8703687787055969,
        "ground_truth": {
          "upregulation": {
            "bertscore": 0.7308995127677917,
            "f1": 0
          }
        }
      }
    },
    "What is the effect of IFN-alpha on c-myc?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.6112488508224487,
        "ground_truth": {
          "downregulation": {
            "bertscore": 0.7352222800254822,
            "f1": 0
          }
        }
      }
    },
    "What is the corresponding effect of IFN-alpha on the c-fo": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.7450111508369446,
        "ground_truth": {
          "responder patients": {
            "bertscore": 0.6776025295257568,
            "f1": 0
          }
        }
      }
    }
  }
}